Previous research has shown that metastatic lung cancer frequently involves the homozygous deletion of CDKN2A. Using The Cancer Proteome Atlas (TCPA) database, decreased CDKN2A protein levels in lung adenocarcinoma were significantly associated with survival survival (log-rank P = 0.036, not shown). Here, CDKN2A is linked to lung adenocarcinoma.